Abstract: The invention relates to an expansion valve (10), for controlling a fluid flow, having a valve means housing (12) and at least one valve means (16), which is movably arranged in a valve means housing (12), and an actuator housing (14), in which the electrical drive of the expansion valve (10) is arranged, wherein the valve means housing (12) is formed substantially at least in part of a metal, in particular of aluminum, and wherein the actuator housing (14) is formed substantially at least in part of plastic and wherein the actuator housing (14) is secured on the valve means housing (12) by means of at least one connection element (40). According to the invention, the connection element (40) is formed at least in part as a latching element and/or clip element.

Abstract: A valve device, in particular solenoid valve device, having at least one throughflow region (12), having at least one valve seat (14) and having an actuating unit (16) which has at least one valve body (18), at least an actuating element (20) provided for transmitting an actuation force to the valve body (18), and at least one first ventilation opening (24) arranged outside a fluid contact region (22) of the actuating element (20). The actuating unit (16) has at least one second ventilation opening (26, 28) arranged outside the fluid contact region (22) of the actuating element (20).

Abstract: A valve device, in particular solenoid valve device, having at least one throughflow region (12), having at least one valve seat (14) and having an actuating unit (16) which has at least one valve body (18), at least an actuating element (20) provided for transmitting an actuation force to the valve body (18), and at least one first ventilation opening (24) arranged outside a fluid contact region (22) of the actuating element (20). The actuating unit (16) has at least one second ventilation opening (26, 28) arranged outside the fluid contact region (22) of the actuating element (20).

Abstract: A solid, non-hygroscopic salt of the Formula (I) ##STR1## wherein R.sup.1 is dydroxy or alkyl;A is C.sub.1 to C.sub.

Abstract: Controlled release pharmaceutical preparations are prepared by homogenizing an organic or inorganic pharmaceutical active substance such as an opium alkaloid or its salts, an opium antagonist or its salts, an aliphatic or aromatic amine derivative or its salts, a phenolate type medicament, or Zn, Fe, Mg, K, Na salts, a fatty acid or its salt necessary to achieve a continuous phase transfer and an ethylene vinyl acetate copolymer and formulating the resulting homogeneous mixture bya) direct compressing orb) admixing with a solvent orc) using a second, auxiliary polymer.The preparations are suitable for oral or rectal administration or for tissue implantation.

Abstract: A solid, non-hygroscopic salt of the Formula (I) ##STR1## wherein R.sup.1 is hydroxy or alkyl;A is C.sub.1 to C.sub.

Abstract: A process is provided for the quantitative selective complexometric analysis of a sample. First and second aliquot parts of a sample containing N-phosphonomethyl-glycine, N-carboxymethyl-N-phosphonomethyl-glycine or N,N-bis-phosphonomethyl-glycine; or N-phosphonomethyl-glycine and N,N-bis-phosphonomethyl-glycine; or N-phosphonomethyl-glycine and N-carboxymethyl-N-phosphonomethyl-glycine are taken. The first aliquot part is titrated with a bismuth volumetric solution at a Ph=1.8-2.5 in the presence of a methylethymol blue indicator. The second aliquot part is titrated with a copper volumetric solution at a Ph=8-10 in the presence of a murexide indicator. Two end point values are obtained and compared. The difference between these two values result in the determination of the content of N-phosphonomethyl-glycine in the sample.

Abstract: The invention relates to a process for the preparation of Chromenes of the general Formula V ##STR1## prepared from chromanone derivatives.

Abstract: The invention relates to a process for the preparation of chromenes of the general Formula V ##STR1## (wherein R.sup.1 and R.sup.2 are hydrogen, optionally halogeno substituted C.sub.1-6 alkyl or aryl;R.sup.3 and R.sup.7 stand for hydrogen, halogen or C.sub.1-6 alkyl;R.sup.4 represents C.sub.1-8 alkyl, aryl, aralkyl or a group containing a carbonyl group;R.sup.5 and R.sup.6 stand for C.sub.1-10 alkyl, aryl, amino, hydroxyalkyl, alkoxyalkenyl, alkylmercaptoalkyl, acyl, carboxy or an ester group or a halogen atom;n is 0 or 1)which comprises(a) for the preparation of compounds, in which R.sup.5 and R.sup.6 stand for different groups, reacting a compound of the general Formula I ##STR2## with an approximately equimolar, preferably 0.8-1.5 molar amount of a reactant of the general Formula R.sup.5 --X-related to the amount of the compound of the general Formula I (wherein R.sup.

Abstract: The invention relates to pesticidal compositions comprising as active ingredient a compound of the general Formula I ##STR1## wherein R.sup.1 and R.sup.2 stand for hydrogen, optionally halogenosubstituted C.sub.1-6 alkyl or aryl;R.sup.3 and R.sup.4 are hydrogen, halogen or C.sub.1-6 alkyl;R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are hydrogen, hydroxy, mercapto, amino, C.sub.1-10 alkyl; a group containing a methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec. butoxy, isobutoxy, tert. butoxy, n-pentyloxy, cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, cyclohexyloxy, cycloheptyloxy, cyclooctyloxy, allyloxy, crotyloxy, prenyloxy, propargyloxy, substituted propargyloxy, C.sub.1-3 alkylenedioxy, aralkoxy, substituted aralkoxy, hydroxyalkoxy, alkoxyalkoxy, mercaptoalkoxyalkoxy, halogenoalkoxy, dihalogenoalkoxy, trihalogenoalkoxy, polyhalogenoalkoxy, N,N-dialkylaminoalkoxy, cycloalkylaminoalkoxy, alkylenoxy-alkyleneoxy, alkylene-thia-alkylenoxy or alkylene-aza-alkylenoxy unit or C.sub.

Abstract: N-phosphonomethylglycine is prepared from glycine and parsformaldehyde to obtain an intermediate which is reacted with dialkylphosphite to obtain an ester of the desired compound which is then hydrolyzed.